no key · no human

bioxconomy API, RSS and sitemap

Every article bioxconomy publishes, as JSON, through an open API with no key and no signup. 167 of their articles are indexed right now, refreshed hourly.

English#9,618 by volume

Four ways to pull bioxconomy.com

All four are ours, all four are live, and none of them needs a key.

JSON Search this publisher

Every article we hold from bioxconomy.com, newest first. Add q= to search inside.

curl -s "https://freenewsapi.ai/v1/search?host=www.bioxconomy.com&size=20"open it →

RSS Subscribe in any reader

The same articles as an RSS 2.0 feed. Works in Feedly, Inoreader, Thunderbird — anywhere.

curl -s "https://freenewsapi.ai/v1/rss?host=www.bioxconomy.com&size=50"open it →

JSON Feed For apps

JSON Feed 1.1, the same content in a format apps parse natively.

curl -s "https://freenewsapi.ai/v1/feed.json?host=www.bioxconomy.com&size=50"open it →

Trimmed For agents

Only the fields an agent needs — title, url, date, language — so the response stays small.

curl -s "https://freenewsapi.ai/v1/search?host=www.bioxconomy.com&size=20&fields=title,url,published_at,lang"open it →

What this outlet covers, by share of its recent output:

health 60%business 40%

Call the API

A live request. Paste it into a terminal and bioxconomy headlines come back as JSON.

bash
curl "https://freenewsapi.ai/v1/search?host=www.bioxconomy.com&size=5"
167
articles indexed
167
in the last 30 days
8
median per day
1
languages
11260 min
median crawl lag
11.08 → 04.09
archive depth

Publishing volume

Articles per day over the last 19 days. The busiest hour is 16:00 UTC — that is when the newsroom pushes its main batch.

2026-08-11: 2 articles2026-08-12: 10 articles2026-08-13: 4 articles2026-08-14: 6 articles2026-08-17: 8 articles2026-08-18: 8 articles2026-08-19: 7 articles2026-08-20: 15 articles2026-08-21: 15 articles2026-08-24: 12 articles2026-08-25: 14 articles2026-08-26: 13 articles2026-08-27: 9 articles2026-08-28: 6 articles2026-08-31: 6 articles2026-09-01: 8 articles2026-09-02: 12 articles2026-09-03: 6 articles2026-09-04: 6 articles08-1108-1408-1908-2408-2709-0109-04
bash
curl "https://freenewsapi.ai/v1/stats?host=www.bioxconomy.com&top=10"

Publishing rhythm

When bioxconomy actually publishes, by hour of day (UTC) and by day of week — measured from 167 timestamps, not from a schedule they advertise.

00: 00001: 00102: 30203: 00304: 00405: 00506: 00607: 60708: 150809: 130910: 121011: 41112: 41213: 151314: 121415: 191516: 231617: 121718: 31819: 01920: 182021: 62122: 02223: 223
Mon: 26MonTue: 32TueWed: 42WedThu: 34ThuFri: 33FriSat: 0SatSun: 0Sun

Sections

Sections come from the publisher's own markup, present on 8% of their articles.

SectionArticles
business14
health14

Languages

CodeLanguageArticlesShare
enEnglish167100.0%

Latest articles

The 18 most recent bioxconomy articles in the index — the same rows the API returns, rendered for humans.

Fair market value 2.0: Managing growth and complexity
2026-09-04 17:34 UTC
Compliance leaders stress industry data, unified rates, and audit-ready documentation to manage fair market value processes at growing companies.
Why cultural intelligence can trump contract terms in cross-border collabs
2026-09-04 14:31 UTC
As biotech partnerships shift eastward, mastering cultural nuances and geopolitical risks matters more than ever for successful international deals.
HUTCHMED Lands $1.3bn GSK deal for cancer therapy
2026-09-04 09:05 UTC
In a deal that could be worth close to $1.3 billion, HUTCHMED has signed a licensing agreement with GSK for one of its oncology assets.
Patient support services violation in Texas
2026-09-03 20:42 UTC
Monthly insights, guidance alerts and blogs from global life sciences law firms, compiled for you in one place.
From private promise to public potential: HaemaLogiX’s journey to market
2026-09-03 11:56 UTC
Going public isn't easy, but HaemaLogiX CEO Chris Baldwin believes transparency and market accountability outweigh the challenges of an IPO journey.
Novartis pays up to $3.2bn to Alteogen for drug delivery technology
2026-09-03 09:20 UTC
Novartis has become the latest global pharmaceutical heavyweight to license Alteogen's subcutaneous drug delivery platform.
Novartis halts CAR T therapy trials due to three patient fatalities, BMS follows
2026-09-02 23:56 UTC
Three patients have died due to a severe autoimmune reaction following dosing with zola-cel for the treatment of autoimmune conditions.
Speed to signal: how large pharmas are rethinking clinical development
2026-09-02 20:46 UTC
Companies focus on early-stage decisions and patient insights to shorten development timelines now.
Digital influencers enter pharma: Navigating the next chapter in HCP engagement
2026-09-02 17:41 UTC
Vishal Khapane of AstraZeneca discusses branded versus unbranded partnerships, fair market value challenges, and adverse event monitoring protocols.
New benchmarking tool can help trial sites identify operational inefficiencies
2026-09-02 16:56 UTC
The framework emerged from expert input across nine countries and aims to standardize how research centers evaluate their performance
Roche pays up to $1.5bn for Simcere Zaiming's trispecific B-cell antibody
2026-09-02 15:00 UTC
Roche has struck an exclusive global licensing agreement for SIM0660, a preclinical trispecific antibody aimed at B-cell-mediated diseases.
Eyes on Asia: K2 Therapeutics, Enginprime, Haisco
2026-09-02 10:09 UTC
BioXconomy presents the Asia biopharma and healthcare dealmaking highlights for the week ending August 31, 2026.
Nine more drugmakers join US pricing initiative
2026-09-01 20:46 UTC
The agreements cover treatments from hemophilia to cancer, with firms pledging nearly $20B in US manufacturing.
African nations excluded from most global drug trials, researchers say
2026-09-01 14:39 UTC
Study reveals only 9% of multicountry clinical trials include African sites, raising concerns about treatment applicability and scientific bias.
Lilly bets $2.8bn on autoimmune therapy with Merida buy
2026-09-01 12:02 UTC
Lilly buys Merida Biosciences for $2.8 billion to advance precision treatments for Graves' disease and thyroid eye disease
Beyond proximity: How connected ecosystems can advance innovation
2026-09-01 09:05 UTC
Strategic partnerships and integrated support systems can transform how biotech startups navigate from early-stage innovation to commercial success across global markets.
Pharma's 340B problem: 35 years of policy drift
2026-08-31 17:28 UTC
New research traces how a 1992 fix for safety-net clinics became a compliance and litigation burden for pharma.
Medicare drug price cuts fail to help patients
2026-08-31 16:42 UTC
Initial rejection rates for negotiated medications remain at 24%, with immunology and oncology hit hardest.

Harvest it all

Page through the archive by date. from and to accept YYYY-MM-DD or relative values such as now-7d.

bash
curl "https://freenewsapi.ai/v1/search?host=www.bioxconomy.com&from=now-7d&size=100"

To poll for new material, keep the timestamp of the newest article you saw and ask only for what came after it:

bash
curl "https://freenewsapi.ai/v1/search?host=www.bioxconomy.com&from=now-1h&sort=date_asc"

Article bodies come with full_text=true. No key, no quota tier, no header — see the search endpoint for every parameter.

Metadata quality

How well bioxconomy marks up its own pages — useful if you are deciding whether to parse them yourself.

0%
dates from JSON-LD
0%
articles with a byline
8%
articles with sections
average page weight

Crawl lag — the delay between publication and the article reaching this index — is 11260 min at the median, 23127 minutes at the 90th percentile.

Similar publishers

Comparable outlets in the same language. Those without a page here yet link straight to their slice of the API.

FAQ

Does bioxconomy have an official API?

Not a public one. This endpoint is the practical alternative: their articles as structured JSON, with title, lead, publication time, section, byline and a link back to the original.

How do I get their RSS feed?

Most publishers expose one at /rss or /feed, but feeds carry only the last few dozen items and drop them within hours. This index keeps 167 of their articles and lets you filter by date, language and section.

How many articles does bioxconomy publish per day?

8 on a median day, measured across 19 days.

Can I use this commercially?

The API is free and unauthenticated. What you may do with the content is between you and the publisher: we return metadata, a lead paragraph and a link, not a licence.